As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/3/22  Baron Capital, Inc.               FOCUSN      2/28/22    1:2K                                     SEC #7                   
  5/3/22  Baron Capital, Inc.               X-17A-5     2/28/22    1:2K                                     SEC #7                   
  5/3/22  Cboe EDGX Exchange, Inc.          19B-4E       5/3/22    1:2K                                     SEC #7                   
  5/3/22  Cboe EDGA Exchange, Inc.          19B-4E       5/3/22    1:2K                                     SEC #7                   
  5/3/22  Cboe BZX Exchange, Inc.           19B-4E       5/3/22    1:2K                                     SEC #7                   
  5/3/22  Cboe BYX Exchange, Inc.           19B-4E       5/3/22    1:2K                                     SEC #7                   
  5/3/22‡ Innovid Corp.                     EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ FT 10099                          EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ Ginkgo Bioworks Holdings, Inc.    EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ Lucid Group, Inc.                 EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ Invesco Unit Trusts Series 2209   EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ Forma Therapeutics Holdings, Inc. EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ CuriosityStream Inc.              EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ Stem, Inc.                        EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ Austin Gold Corp.                 EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ G1 Therapeutics, Inc.             EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ Acelrx Pharmaceuticals Inc.       EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ NRX Pharmaceuticals, Inc.         EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ CuriosityStream Inc.              EFFECT       5/3/22    1:2K                                     SEC #5                   
  5/3/22‡ Stem, Inc.                        EFFECT       5/3/22    1:2K                                     SEC #5                   

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:
	19B-4E	Info from a Self-Regulatory Organization (SRO) Listing and Trading a New Derivative Securities Product — Form 19b-4(e).
	EFFECT	SEC Notice of Effectiveness.
	FOCUSN	Annual Audit Report on a Financial Report [ a.k.a. FOCUS Report ] by a Broker or Dealer.
	X-17A-5	Annual Financial Report [ a.k.a. FOCUS Report ] by a Broker or Dealer — Form X-17A-5.